Page 13 - Read Online

Bhardwaj MicroRNAs in atopic dermatitis

cells regulates tissue inflammation by producing interleukin 17. Nat 29. Wei T, Orfanidis K, Xu N, Janson P, Ståhle M, Pivarcsi A, Sonkoly E.
Immunol 2005;6:1133-41. The expression of microRNA-203 during human skin morphogenesis.
9. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible Exp Dermatol 2010;19:854-6.
pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 30. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene:
2008;128:2625-30. a typical multifunctional microRNA. Biochim Biophys Acta
10. Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Büchau A, 2009;1792:497-505.
Steinmeyer A, Zügel U, Ruzicka T, Schauber J. Vitamin D analogs 31. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy
differentially control antimicrobial peptide/”alarmin” expression in A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M,
psoriasis. PLoS One 2009;4:e6340. Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the
11. Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, germinal center response by microRNA-155. Science 2007;316:604-8.
Christodoulopoulos P, Fukuda T, Elias JA, Hamid QA. Polarized in 32. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR,
vivo expression of IL-11 and IL-17 between acute and chronic skin van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug
lesions. J Allergy Clin Immunol 2003;111:875-81. K, Enright AJ, Dougan G, Turner M, Bradley A. Requirement of bic/
12. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification microRNA-155 for normal immune function. Science 2007;316:608-
of a human helper T cell population that has abundant production of 11.
interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat 33. Banerjee A, Schambach F, DeJong CS, Hammond SM, Reiner SL.
Immunol 2009;10:864-71. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J
13. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Immunol 2010;40:225-31.
Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E. 34. Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L,
IL-22-producing “T22” T cells account for upregulated IL-22 in atopic Xu N, Meisgen F, Wei T, Bradley M, Stenvang J, Kauppinen S, Alenius
dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy H, Lauerma A, Homey B, Winqvist O, Ståhle M, Pivarcsi A. MiR-155
Clin Immunol 2009;123:1244-52.e2. is overexpressed in patients with atopic dermatitis and modulates T-cell
14. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suárez- proliferative responses by targeting cytotoxic T lymphocyte-associated
Fariñas M, Cardinale I, Khatcherian A, Gonzalez J, Pierson KC, White antigen 4. J Allergy Clin Immunol 2010;126:581-9.e1-20.
TR, Pensabene C, Coats I, Novitskaya I, Lowes MA, Krueger JG. Th17 35. Sonkoly E, Pivarcsi A. Advances in microRNAs: implications for
cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory immunity and inflammatory diseases. J Cell Mol Med 2009;13:24-38.
and keratinocyte-response pathways. Br J Dermatol 2008;159:1092- 36. Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh
102. L, Mathieu C, Ceuppens JL. Blockade of CTLA-4 enhances allergic
15. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated sensitization and eosinophilic airway inflammation in genetically
with skin and allergic diseases. N Engl J Med 2011;365:1315-27. predisposed mice. Eur J Immunol 2002;32:585-94.
16. McAleer MA, Irvine AD. The multifunctional role of filaggrin in 37. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb
allergic skin disease. J Allergy Clin Immunol 2013;131:280-91. MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner
17. Mohiuddin MS, Ramamoorthy P, Reynolds PR, Curran-Everett D, RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger
Leung DY. Increased compound heterozygous filaggrin mutations in JG, Ochs HD, Kelley SL, Kang S. CTLA4Ig-mediated blockade of
severe atopic dermatitis in the United States. J Allergy Clin Immunol T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest
Pract 2013;1:534-6. 1999;103:1243-52.
18. Samuelov L, Sprecher E. Peeling off the genetics of atopic dermatitis- 38. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-
like congenital disorders. J Allergy Clin Immunol 2014;134:808-15. dependent induction of microRNA miR-146, an inhibitor targeted to
19. Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate signaling proteins of innate immune responses. Proc Natl Acad Sci U S
immune response in patients with atopic dermatitis. J Allergy Clin A 2006;103:12481-6.
Immunol 2013;131:266-78. 39. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting
20. Rebane A, Akdis CA. MicroRNAs: Essential players in the regulation pathogenesis of atopic dermatitis and psoriasis--part II: immune
of inflammation. J Allergy Clin Immunol 2013;132:15-26. cell subsets and therapeutic concepts. J Allergy Clin Immunol
21. Makeyev EV, Maniatis T. Multilevel regulation of gene expression by 2011;127:1420-32.
microRNAs. Science 2008;319:1789-90. 40. Boldin MP, Baltimore D. MicroRNAs, new effectors and regulators of
22. Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs: novel regulators in skin NF-κB. Immunol Rev 2012;246:205-20.
inflammation. Clin Exp Dermatol 2008;33:312-5. 41. Etzrodt M, Cortez-Retamozo V, Newton A, Zhao J, Ng A, Wildgruber
23. Lu TX, Rothenberg ME. Diagnostic, functional, and therapeutic roles M, Romero P, Wurdinger T, Xavier R, Geissmann F, Meylan E,
of microRNA in allergic diseases. J Allergy Clin Immunol 2013;132:3- Nahrendorf M, Swirski FK, Baltimore D, Weissleder R, Pittet MJ.
13; quiz 4. Regulation of monocyte functional heterogeneity by miR-146a and
24. Rebane A. microRNA and allergy. Adv Exp Med Biol 2015;888:331-52. Relb. Cell Rep 2012;1:317-24.
25. Yi R, O’Carroll D, Pasolli HA, Zhang Z, Dietrich FS, Tarakhovsky 42. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH,
A, Fuchs E. Morphogenesis in skin is governed by discrete sets of Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-
differentially expressed microRNAs. Nat Genet 2006;38:356-62. mediated activation of NF-κB by targeting CARD10 and COPS8 in
26. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder gastric cancer. Mol Cancer 2012;11:71.
M, Norstedt G, Alenius H, Homey B, Scheynius A, Ståhle M, Pivarcsi 43. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T,
A. MicroRNAs: novel regulators involved in the pathogenesis of Yoshimura A, Baltimore D, Rudensky AY. Function of miR-146a
psoriasis? PLoS One 2007;2:e610. in controlling Treg cell-mediated regulation of Th1 responses. Cell
27. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes 2010;142:914-29.
differentiation by repressing ‘stemness’. Nature 2008;452:225-9. 44. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M,
28. Candi E, Cipollone R, Rivetti di Val Cervo P, Gonfloni S, Melino Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley
G, Knight R. p63 in epithelial development. Cell Mol Life Sci PS, Baltimore D. miR-146a is a significant brake on autoimmunity,
2008;65:3126-33. myeloproliferation, and cancer in mice. J Exp Med 2011;208:1189-201.

Journal of Translational Genetics and Genomics ¦ Volume 1 ¦ November 17, 2017 21